China agrees to reclassify fentanyl after meeting with US at G20 summit

Image
ANI Buenos Aires [Argentina]
Last Updated : Dec 03 2018 | 11:00 AM IST

China has decided to reclassify 'fentanyl' as a 'controlled substance', following the meeting between United States President Donald Trump and Chinese President Xi Jinping on the sidelines of G20 summit in Buenos Aires on Saturday.

According to a statement released by China's Foreign Ministry, Beijing has "decided to schedule the entire category of fentanyl-type substances as controlled substances, and start the process of revising relevant laws and regulations."

White House termed the decision a "wonderful humanitarian gesture," reported CNN.

Washington and Beijing have also agreed to take active measures to strengthen cooperation on law enforcement and narcotics control which includes reclassification and control of fentanyl-type substances, stated the press statement.

In a statement, the White House divulged that according to the new agreement people in China involved in the selling of fentanyl to the US, "will be subject to China's maximum penalty under the law."

Fentanyl is a drug which is 50 to 100 times more potent than morphine and 30 to 50 times more potent than heroin.

The US was keen on ending the opioid crisis in the country and this step from China will help further the cause.

White House also stated that the US has agreed to maintain the 10 per cent tariffs on 200 billion USD worth of Chinese goods, instead of raising them to 25 per cent.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 03 2018 | 11:00 AM IST

Next Story